CBPE Capital has acquired a majority ownership position in IDEAL Networks, a market leading Industrial Technology business which provides portable handsets for data cable and network testing, validation and certification. PMSI provided commercial due diligence (CDD) advice for the deal.
IDEAL Networks’ products improve the productivity of qualified engineers who install, test and maintain network cabling and services. They work by simulating data flow to provide network diagnostics, enabling the engineers to certify newly installed network cabling or to resolve network issues across both Local Area Networks (LAN) and Wide Area Networks (WAN). IDEAL Networks is a global business, with sales across the EMEA, North America, Latin America and Asia.
CBPE will work with management to build on IDEAL Networks’ reputation for product innovation and will invest in research and development. The business will continue to offer market leading products developed to suit the needs of its end users.
CBPE’s investment in IDEAL Networks was led by Mathew Hutchinson with support from Ben Lewis, James Whittington and Aqil Sohail. Mathew Hutchinson and Ben Lewis will join the Board of IDEAL Networks.
Mathew Hutchinson, Partner, CBPE said:
“IDEAL Networks has successfully established a reputation for quality and service in an attractive and growing market, and we are confident that the business will thrive under independent ownership. We will work with the management team and support their commitment to continue to offer innovative products and services which match the needs of the customer base.”
Paul Walsh, CEO of IDEAL Networks said:
“We are delighted to be working with CBPE and look forward to establishing IDEAL Networks as a successful, independent market leader. IDEAL INDUSTRIES has been a supportive owner and has enabled us to reach this stage of our development. With CBPE, we are confident we have found a partner that will provide valuable input as we pursue our exciting growth plans.”
CDD for Apposite Capital's acquisition of Crest...
Apposite Capital has acquired a majority share holding in CrestOptics, a world leader in the development and manufacture of advanced systems for fluorescence...
CDD for Chiltern's investment into Surepharm
Chiltern has completed an investment in Centaur Healthcare Limited (trading as “Surepharm”), a contract development manufacturing organisation (CDMO) predomi...